Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 94   

Articles published

NVO 46.08 +2.58 (5.92%)
price chart
Sanofi And Novo Nordisk's Basal-Insulin Battle Continues
Sanofi SA (ADR) (SNY) and Novo Nordisk A/S (ADR) (NVO) are the two main players in the ongoing race for developing effective basal insulin therapies for the treatment of diabetes.
Related articles »  
News Buzz � Novo Nordisk A/S (ADR) (NYSE:NVO), Standard Pacific Corp ...
Manhattan, NY- 28 October, 2014 - (Techsonian) - Novo Nordisk A/S (ADR) (NYSE:NVO) engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark.
Related articles »  
Big Movers: Coach, Inc. (NYSE:COH), Novo Nordisk A/S (ADR)(NYSE:NVO ...
Lakeway, NY - (MARKET NEWS CALL) - 10/28/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Novo Nordisk A/S Receives "Neutral" Rating from Zacks (NVO)
Novo Nordisk A/S (ADR) logo Zacks reissued their neutral rating on shares of Novo Nordisk A/S (NYSE:NVO) in a research report sent to investors on Monday morning.
Traders Alert - Altria Group Inc (NYSE:MO), Novo Nordisk A/S (ADR) (NYSE ...  Techsonian (press release)
Related articles »  
Investor's Alert �Novo Nordisk A/S (ADR) (NVO), Entergy Corporation (NYSE ...
Las Vegas, NV - October 03, 2014� (TechSonian) - Novo Nordisk A/S (ADR) (NYSE:NVO) posted that it is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products.
Related articles »  
Stocks in the News �Novo Nordisk A/S (ADR) (NYSE:NVO), The Dow Chemical ...
Manhattan, NY- October 10, 2014 - (Techsonian) - Novo Nordisk A/S (ADR) (NYSE:NVO) posted that it is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products.
Related articles »  
Novo Nordisk A/S Given Neutral Rating at Zacks (NVO)
Novo Nordisk A/S (ADR) logo Zacks restated their neutral rating on shares of Novo Nordisk A/S (NYSE:NVO) in a research note issued to investors on Monday.
Related articles »  
Watch List - Aetna Inc (NYSE:AET), Novo Nordisk A/S (ADR) (NYSE:NVO ...
Las Vegas, NV - 24 October, 2014 - (Investorwired) - Penny Stock Earnings is comprised of a team of vetted penny stock traders who've been trading since 2008 & have developed the skills needed to trade for consistent profits through eMail and text ...
Novo Nordisk A/S Stock Rating Reaffirmed by Zacks (NVO)
Novo Nordisk A/S (ADR) logo Novo Nordisk A/S (NYSE:NVO)'s stock had its �neutral� rating reissued by Zacks in a research note issued on Monday.
Small Cap Losers:Amkor Technology (NASDAQ:AMKR), NQ Mobile Inc (ADR ...
On 24 October Novo Nordisk A/S (ADR) (NYSE:NVO) said it has been served with a subpoena by a U.S. Attorney requesting documents regarding potential manufacturing issues within its Danish production units.
Related articles »